| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.11 | 0.008 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.008 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.087 | 0.008 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.009 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.081 | 0.01 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.14 | 0.01 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.01 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.01 |